Concepedia

Niharika Nath

NN

20

Publications

1.4K

Citations

17

H-Index

1995

Active since

Affiliations

City University of New York(Current)

New York Institute of Technology

New York Medical College

National Cancer Institute

Columbia University

Niharika Nath is an author at City University of New York specializing in medicine, cell biology, and pharmacology.

Top concepts

MedicineCell BiologyPharmacologyCell SignalingTumor BiologyCancer ResearchOxidative StressSignal TransductionCell DeathImmunology

Publications per year

1995–2020

20

Publications

20

Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function

Sheng Wang, Niharika Nath, Matthew Adlam et al. · Oncogene · 1999 · 234 citations

Signal Transduction, Signaling Pathway, Cell Regulation +9

Rb and Prohibitin Target Distinct Regions of E2F1 for Repression and Respond to Different Upstream Signals

Sheng Wang, Niharika Nath, Gina Fusaro et al. · Molecular and Cellular Biology · 1999 · 166 citations · Full text

E2f Activity, Genetics, Immunology +17

PAK5, a New Brain-Specific Kinase, Promotes Neurite Outgrowth in N1E-115 Cells

Chuntao Dan, Niharika Nath, Muriel Liberto et al. · Molecular and Cellular Biology · 2002 · 164 citations · Full text

Rho Gtpases Cdc42, Cytoskeleton, Cellular Physiology +18

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 129 citations

Human Cancer Cells, Anti-inflammatory, Biochemistry +8

Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association

Niharika Nath, Khosrow Kashfi, Jie Chen et al. · Proceedings of the National Academy of Sciences · 2003 · 116 citations · Full text

Rows per page

1–5 of 20